TCR Therapy Market to Witness Promising Growth Opportunities by 2024-2035
T-cell receptor (TCR)-based therapies represent an important area of development within the broader field of cancer immunotherapy. Unlike conventional approaches that primarily target antigens present on the cell surface, TCR therapies can potentially recognize peptide fragments presented by major histocompatibility complex molecules, expanding the range of targets that may be addressed.
For more information on the TCR-based therapies market, visit:
https://www.rootsanalysis.com/....reports/tcr-based-th